Suggestions
Dr.Raj Subramanian, PhD, PMP
Co-founder #AI #imagingdiagnostics #digitalpathology #breastcancer #healthtech #womenshealth #Cybersecurity
Dr. Raj Subramanian, PhD, PMP, is a Principal Researcher at the Institute of Technology, specializing in digital clinics research. With over four years of experience in genomic data science, he has developed algorithms for data and pattern mining, as well as machine learning using programming languages such as Java, R, and Python.1
In addition to his research work, Dr. Subramanian is actively involved in discussions surrounding healthcare technology, particularly in improving breast cancer diagnosis and treatment through innovative medical technologies.24 He has also contributed to the discourse on the intersection of healthcare budgets and artificial intelligence.3
Dr. Subramanian's expertise extends to co-founding initiatives related to AI in imaging diagnostics and digital pathology, emphasizing his commitment to advancing health tech solutions for women's health.15
Highlights
Dr.Raj Subramanian, PhD, PMP Dr. Devika Rubi (Devika) Digital Clinics Research and Services Pvt Ltd Cancer is a battle against time, precious life. Starting with initial cancer screening, histology diagnostics/grading, leading to weeks waiting time. In addition, NGS tests (after grading assessed) takes extremely long lead times to identify responsive patients to identified therapy.
Our clinical utility #MBC_oncoVision, predicts targeted therapy recommendations for Breast Cancer through biomarkers identification at pathology diagnosis. Accelerate insurance approvals, ensuring faster access to effective therapies and enhancing patient survival rates.
A Clinical Utility : Swift Diagnose &&& Cancer Grade+SubType &&& Clinical Actionable Biomarker ------>> Recommend precision therapies
#TransformingCancerCare: A Race Against Time A Clinical Utility – Swift Diagnose + Cancer Grade + Clinical Actionable Biomarker Recommend precision therapies Revolutionize Precision Cancer Therapy, thro DigitalPathologyAI diagnostics blended with Cancer Grading and clinical biomarker identification
#SwiftandAccurateDiagnoses Diagnosis with relevant biomarkers -> Significantly reducing financial burdens, Saving crucial time and precious lives Swift therapy decisions for oncologists -> Improved patient outcomes
#EfficiencyforAllStakeholders Accelerates right therapy insurance payments with AI driven therapy decisions at right-time Faster and more efficient patient care with precision, efficiency, and compassion
#digitalpathology #MBC_oncoVision #breastcancer #nottinghamgrading
Dr.Raj Subramanian, PhD, PMP Dr. Devika Rubi (Devika) Digital Clinics Research and Services Pvt Ltd
MedTech Innovators face these paradox. 1.Adoption requires Evidence. But evidence comes only from adoption. Clinical data can not be synthetic data for good AI. 2.Regulatory, validation requires money. But investors require regulatory, validation. 3.MedTech need faster adoption, but healthcare is slower among every profession, a cut-throat industry. They won't use it, if it is more than 2-3 clicks.
Each breast tissue sample represents someone’s life, questions, hopes and aspirations.
Cancer is personal, and #digitalclinics believes that Cancer Care also should be personal.
#TransformingCancerCare: A Race Against Time A Clinical Utility – Swift Diagnose + Cancer Grade + Clinical Actionable Biomarker Recommend precision therapies
Revolutionize Precision Cancer Therapy, thro DigitalPathologyAI diagnostics blended with Cancer Grading and clinical biomarker identification at Path Diagnosis
#digitalpathology #breastcancer #nottinghamgrading
